A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
NCT05669092
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
174
Enrollment
OTHER
Sponsor class
Conditions
Toripalimab
Radiation
Interventions
DRUG:
Toripalimab
RADIATION:
CRT
RADIATION:
SCRT
DRUG:
XELIRI
DRUG:
FOLFRINOX
Sponsor
Zhejiang Cancer Hospital